These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

489 related items for PubMed ID: 16730487

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Bone mineral density changes over two years in first-time users of depot medroxyprogesterone acetate.
    Clark MK, Sowers MR, Nichols S, Levy B.
    Fertil Steril; 2004 Dec; 82(6):1580-6. PubMed ID: 15589863
    [Abstract] [Full Text] [Related]

  • 5. Depo Provera. Position paper on clinical use, effectiveness and side effects.
    Bigrigg A, Evans M, Gbolade B, Newton J, Pollard L, Szarewski A, Thomas C, Walling M.
    Br J Fam Plann; 1999 Jul; 25(2):69-76. PubMed ID: 10454658
    [Abstract] [Full Text] [Related]

  • 6. Bone mineral density in women using depot medroxyprogesterone acetate (DMPA) for at least 2 years compared to a control group: a cross sectional study.
    Pongsatha S, Ekmahachai M, Chaovisitsaree S, Suntornlimsiri N, Morakote N.
    J Med Assoc Thai; 2009 Oct; 92(10):1263-7. PubMed ID: 19845231
    [Abstract] [Full Text] [Related]

  • 7. Effects of the long-term use of depot medroxyprogesterone acetate as hormonal contraceptive on bone mineral density and biochemical markers of bone remodeling.
    Shaarawy M, El-Mallah SY, Seoudi S, Hassan M, Mohsen IA.
    Contraception; 2006 Oct; 74(4):297-302. PubMed ID: 16982229
    [Abstract] [Full Text] [Related]

  • 8. Recovery of bone mineral density in adolescents following the use of depot medroxyprogesterone acetate contraceptive injections.
    Harel Z, Johnson CC, Gold MA, Cromer B, Peterson E, Burkman R, Stager M, Brown R, Bruner A, Coupey S, Hertweck P, Bone H, Wolter K, Nelson A, Marshall S, Bachrach LK.
    Contraception; 2010 Apr; 81(4):281-91. PubMed ID: 20227543
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Bone density in women receiving depot medroxyprogesterone acetate for contraception.
    Cundy T, Evans M, Roberts H, Wattie D, Ames R, Reid IR.
    BMJ; 1991 Jul 06; 303(6793):13-6. PubMed ID: 1830502
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Forearm bone mineral density in postmenopausal former users of depot medroxyprogesterone acetate.
    Sanches L, Marchi NM, Castro S, Juliato CT, Villarroel M, Bahamondes L.
    Contraception; 2008 Nov 06; 78(5):365-9. PubMed ID: 18929732
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effects of hormonal contraception on bone mineral density after 24 months of use.
    Berenson AB, Breitkopf CR, Grady JJ, Rickert VI, Thomas A.
    Obstet Gynecol; 2004 May 06; 103(5 Pt 1):899-906. PubMed ID: 15121563
    [Abstract] [Full Text] [Related]

  • 18. Bone mineral density and DMPA.
    Westhoff C.
    J Reprod Med; 2002 Sep 06; 47(9 Suppl):795-9. PubMed ID: 12380409
    [Abstract] [Full Text] [Related]

  • 19. Bone mineral density, fracture, and vitamin D in adolescents and young women using depot medroxyprogesterone acetate.
    Pitts SA, Feldman HA, Dorale A, Gordon CM.
    J Pediatr Adolesc Gynecol; 2012 Feb 06; 25(1):23-6. PubMed ID: 22078997
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.